Chemotherapy of malignant melanoma.
D003630:Daunorubicin / Q000008:administration & dosage; D003998:Dicarboxylic Acids / Q000008:administration & dosage; D004338:Drug Combinations; D004351:Drug Resistance; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D009074:Melanocyte-Stimulating Hormones / Q000008:administration & dosage; D008545:Melanoma / Q000032:analysis / Q000188:drug therapy* / Q000378:metabolism; D008727:Methotrexate / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000032:analysis; D014212:Tretinoin / Q000494:pharmacology
D003998:Dicarboxylic Acids; D004338:Drug Combinations; D009607:Nitrosourea Compounds; D011960:Receptors, Estrogen; D007980:Levodopa; D014212:Tretinoin; D009074:Melanocyte-Stimulating Hormones; D008727:Methotrexate; D003630:Daunorubicin